These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 17574594

  • 1. Bcl-2 gene silencing in pediatric epithelial liver tumors.
    Warmann SW, Frank H, Heitmann H, Ruck P, Herberts T, Seitz G, Fuchs J.
    J Surg Res; 2008 Jan; 144(1):43-8. PubMed ID: 17574594
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of Bcl-2 and Bcl-X enhances chemotherapy sensitivity in hepatoblastoma cells.
    Lieber J, Kirchner B, Eicher C, Warmann SW, Seitz G, Fuchs J, Armeanu-Ebinger S.
    Pediatr Blood Cancer; 2010 Dec 01; 55(6):1089-95. PubMed ID: 20680965
    [Abstract] [Full Text] [Related]

  • 3. Effects of Bcl-2 and Bcl-XL protein levels on chemoresistance of hepatoblastoma HepG2 cell line.
    Luo D, Cheng SC, Xie H, Xie Y.
    Biochem Cell Biol; 2000 Dec 01; 78(2):119-26. PubMed ID: 10874473
    [Abstract] [Full Text] [Related]

  • 4. Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction.
    Schulze-Bergkamen H, Fleischer B, Schuchmann M, Weber A, Weinmann A, Krammer PH, Galle PR.
    BMC Cancer; 2006 Oct 02; 6():232. PubMed ID: 17014711
    [Abstract] [Full Text] [Related]

  • 5. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
    Sawada S, Mese H, Sasaki A, Yoshioka N, Matsumura T.
    Cancer Chemother Pharmacol; 2003 Jun 02; 51(6):505-11. PubMed ID: 12709826
    [Abstract] [Full Text] [Related]

  • 6. Bcl-2 and Bcl-xL are important for the induction of paclitaxel resistance in human hepatocellular carcinoma cells.
    Chun E, Lee KY.
    Biochem Biophys Res Commun; 2004 Mar 12; 315(3):771-9. PubMed ID: 14975768
    [Abstract] [Full Text] [Related]

  • 7. In vitro photodynamic therapy in pediatric epithelial liver tumors promoted by hypericin.
    Seitz G, Krause R, Fuchs J, Heitmann H, Armeanu S, Ruck P, Warmann SW.
    Oncol Rep; 2008 Nov 12; 20(5):1277-82. PubMed ID: 18949433
    [Abstract] [Full Text] [Related]

  • 8. Synergistic antitumoral activity and induction of apoptosis by novel pan Bcl-2 proteins inhibitor apogossypolone with adriamycin in human hepatocellular carcinoma.
    Mi JX, Wang GF, Wang HB, Sun XQ, Ni XY, Zhang XW, Tang JM, Yang DJ.
    Acta Pharmacol Sin; 2008 Dec 12; 29(12):1467-77. PubMed ID: 19026166
    [Abstract] [Full Text] [Related]

  • 9. RNA interference is a functional pathway with therapeutic potential in human myeloid leukemia cell lines.
    Cioca DP, Aoki Y, Kiyosawa K.
    Cancer Gene Ther; 2003 Feb 12; 10(2):125-33. PubMed ID: 12536201
    [Abstract] [Full Text] [Related]

  • 10. Dexamethasone decreases hepatocellular carcinoma cell sensitivity to cisplatin-induced apoptosis.
    Yang N, Zhang H, Si-Ma H, Fu Y, Zhao W, Li D, Yang G.
    Hepatogastroenterology; 2011 Feb 12; 58(110-111):1730-5. PubMed ID: 21940343
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells.
    Lima RT, Martins LM, Guimarães JE, Sambade C, Vasconcelos MH.
    Cancer Gene Ther; 2004 May 12; 11(5):309-16. PubMed ID: 15031723
    [Abstract] [Full Text] [Related]

  • 13. RAIDD expression is impaired in multidrug resistant osteosarcoma cell lines.
    Yang C, Hornicek FJ, Wood KB, Schwab JH, Mankin H, Duan Z.
    Cancer Chemother Pharmacol; 2009 Aug 12; 64(3):607-14. PubMed ID: 19125251
    [Abstract] [Full Text] [Related]

  • 14. Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy.
    Sieghart W, Losert D, Strommer S, Cejka D, Schmid K, Rasoul-Rockenschaub S, Bodingbauer M, Crevenna R, Monia BP, Peck-Radosavljevic M, Wacheck V.
    J Hepatol; 2006 Jan 12; 44(1):151-7. PubMed ID: 16289418
    [Abstract] [Full Text] [Related]

  • 15. Synergism of hydroxyapatite nanoparticles and recombinant mutant human tumour necrosis factor-alpha in chemotherapy of multidrug-resistant hepatocellular carcinoma.
    Li G, Dong S, Qu J, Sun Z, Huang Z, Ye L, Liang H, Ai X, Zhang W, Chen X.
    Liver Int; 2010 Apr 12; 30(4):585-92. PubMed ID: 19780956
    [Abstract] [Full Text] [Related]

  • 16. Taxol induced Bcl-2 protein phosphorylation in human hepatocellular carcinoma QGY-7703 cell line.
    Cheng SC, Luo D, Xie Y.
    Cell Biol Int; 2001 Apr 12; 25(3):261-5. PubMed ID: 11352500
    [Abstract] [Full Text] [Related]

  • 17. Transfection of Smac sensitizes tumor cells to etoposide-induced apoptosis and eradicates established human hepatoma in vivo.
    Zhao J, Jin J, Zhang X, Shi M, Dai J, Wu M, Wang R, Guo Y.
    Cancer Gene Ther; 2006 Apr 12; 13(4):420-7. PubMed ID: 16211087
    [Abstract] [Full Text] [Related]

  • 18. P-glycoprotein mediates celecoxib-induced apoptosis in multiple drug-resistant cell lines.
    Fantappiè O, Solazzo M, Lasagna N, Platini F, Tessitore L, Mazzanti R.
    Cancer Res; 2007 May 15; 67(10):4915-23. PubMed ID: 17510421
    [Abstract] [Full Text] [Related]

  • 19. Adenovirus vector expressing mda-7 selectively kills hepatocellular carcinoma cell line Hep3B.
    Xue XB, Chen K, Wang CJ, Zheng JW, Yu Y, Peng ZH, Wu ZD.
    Hepatobiliary Pancreat Dis Int; 2008 Oct 15; 7(5):509-14. PubMed ID: 18842498
    [Abstract] [Full Text] [Related]

  • 20. [Involvement of bcl-2 in multidrug resistance in human small cell lung cancer cell subline H446/DDP].
    Ji FY, Qian GS, Qian P, Chen Y, Guo RL, Li SP, Huang GJ.
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Mar 15; 29(3):156-60. PubMed ID: 16677475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.